Success Stories: Translating Insights from Genetic Analyses in Painful Small Fiber Neuropathy into Pharmacological Practice - Lacosamide

Thank you

This live web event has ended. Thank you for attending.

Description

Join Karin Faber for the first 2022 Global Year for Translating Pain Knowledge to Practice webinar. This webinar will focus on Lacosamide, a Food and Drug Administration approved treatment for epilepsy, and how insights from the genetic analyses of pain patients led to its investigation for use in the management of neuropathic pain. After you register, please use the "Synopsis" tab above to view the presentation's abstract.

Featuring a presentation by Karin Faber, MD, PhD, Maastricht University, the Netherlands, and moderated by Heike Rittner, MD, University Hospital of Wuerzburg, Germany.

Contributors

Karin Faber, MD, PhD

Karin Faber, MD, PhD, is a full Professor in Neuromuscular Disorders as well as the medical director of the Maastricht University Medical Center, the Netherlands. She has extensive experience in the neuromuscular field, especially in muscle neurodegenerative disorders and painful/small fiber neuropathies. She is the head of the skin-biopsy lab in Maastricht, which published the largest normative values worldwide, and helps to lead ongoing painful/small fiber neuropathy randomized trials and all research activities in the neuromuscular field in Maastricht. She is authored on over 160 peer-reviewed papers, including reviews and book chapters. Her research in the past five years has focused on the genetic causes of small fiber neuropathy, more specifically on sodium channelopathies.
Heike Rittner, MD

Heike Rittner, MD, is a clinician scientist and a professor at the Center of Interdisciplinary Pain Medicine in the Department of Anesthesiology at the University Hospital of Wuerzburg since 2008. She obtained her medical degree from the Universities of Vienna, Austria, and Wuerzburg, Germany. After a postdoc at the Mayo Clinic, she completed her residency at the Charité, Berlin, and was board-certified in Anesthesiology and Pain Medicine. Since 2021, she heads the Center of Interdisciplinary Pain Medicine including the acute pain service as well as ambulatory, outpatient, and in-patient pain treatment.
In parallel she pursued her scientific career in understanding inflammatory and neuropathic pain generation and resolution in the peripheral nervous system. She employs advanced preclinical rodent models, and state-of-the-art animal behavioral portfolios, patients’ biomaterials, as well as in vitro cellular systems for barriers and neuronal structures to decipher these pathways. She has published over 90 papers in peer-reviewed journals and receives funds from German and European Funding agencies.

Success Stories: Translating Insights from Genetic Analyses in Painful Small Fiber Neuropathy into Pharmacological Practice - Lacosamide
Success Stories- Translating Insights from Genetic Analyses in Painful Small Fiber Neuropathy into Pharmacological Practice - Lacosamide.pdf